البلد: المملكة المتحدة
اللغة: الإنجليزية
المصدر: MHRA (Medicines & Healthcare Products Regulatory Agency)
Fluconazole
Mawdsley-Brooks & Company Ltd
J02AC01
Fluconazole
50mg
Oral capsule
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 05020100
To treat mucosal infections affecting 200 mg to 400 mg on the first the lining of the mouth, throat and day then 100 mg to 200 mg until denture sore mouth you are told to stop To treat mucosal thrush – dose 50 mg to 400 mg once daily for 7 depends on where the infection is to 30 days until you are told to located stop To stop mucosal infections affecting 100 mg to 200 mg once daily, or the lining of the mouth, throat 200 mg 3 times a week, while you are at risk of getting an infection To treat genital thrush 150 mg as a single dose To reduce recurrence of vaginal thrush 150 mg every third day for a total of 3 doses (day 1, 4 and 7) and then once a week for 6 months while you are at risk of getting an infection To treat fungal skin and nail infections Depending on the site of the infection 50 mg once daily, 150 mg once weekly, 300 to 400 mg once weekly for 1 to 4 weeks (Athlete’s foot may be up to 6 weeks, for nail infection treatment until infected nail is replaced) To stop you from getting an infection 200 mg to 400 mg once daily caused by Candida (if your immune while you are at risk of getting system is weak and not working an infection properly) USE IN CHILDREN AND ADOLESCENTS The capsules formulation may be unsuitable for children under 5-6 years of age. ADOLESCENTS FROM 12 TO 17 YEARS OLD Follow the dose prescribed by your doctor (either adults or children posology). CHILDREN TO 11 YEARS OLD The maximum dose for children is 400 mg daily. The dose will be based on the child’s weight in kilograms. CONDITION DAILY DOSE Mucosal thrush and throat infections 3 mg per kg of body weight (6 caused by Candida – dose and mg per kg of body weight might duration depends on the severity of be given on the first day) the infection and on where the infection is located Cryptococcal meningitis or internal 6 mg to 12 mg per kg of body fungal infections caused by Candida weight To stop children from getting an 3 mg to 12 mg per kg of body infection caused by Candida (if their weight immune system is not working proper اقرأ الوثيقة كاملة
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Fluconazole 50mg Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains fluconazole 50mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Hard gelatin capsule Size 4, white/green capsules containing white crystalline powder 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Fluconazole capsule is indicated in the following fungal infections (see section 5.1). Fluconazole capsule is indicated in adults for the treatment of: • Cryptococcal meningitis (see section 4.4). • Coccidioidomycosis (see section 4.4). • Invasive candidiasis. • Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis. • Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient. • Vaginal candidiasis, acute or recurrent; when local therapy is not appropriate. • Candidal balanitis when local therapy is not appropriate. • Dermatomycosis including _tinea pedis_, _tinea corporis_, _tinea cruris_, _tinea versicolor_ and dermal _candida_ infections when systemic therapy is indicated. •_ Tinea unguinium (onychomycosis)_ when other agents are not considered appropriate. Fluconazole capsule is indicated in adults for the prophylaxis of: • Relapse of cryptococcal meningitis in patients with high risk of recurrence. • Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse. • To reduce the incidence of recurrent vaginal candidiasis (4 or more episodes a year). • Prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving Hematopoietic Stem Cell Transplantation (see section 5.1)). Fluconazole capsule is indicated in term newborn infants, infants, toddlers, children, and adolescents aged from 0 to 17 years old: Fluconazole capsule is اقرأ الوثيقة كاملة